3/19/2013

The European Medicines Agency approved Roche Holding's Pegasys, or peginterferon alfa-2a, in combination with ribavirin, to treat chronic hepatitis C in pediatric patients 5 and older.

Full Story:
Fox Business, Reuters

Related Summaries